Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
11.23
-0.19 (-1.66%)
At close: Sep 12, 2025, 4:00 PM EDT
11.59
+0.36 (3.21%)
After-hours: Sep 12, 2025, 7:42 PM EDT

Greenwich LifeSciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
Net Income
-17.99-15.79-8.89-7.83-4.57-1.86
Upgrade
Depreciation & Amortization
000000
Upgrade
Stock-Based Compensation
9.157.252.381.740.660.68
Upgrade
Change in Accounts Payable
-0.040.920.04--0.53-0.09
Upgrade
Change in Other Net Operating Assets
0.370.34-0-0.120.140.12
Upgrade
Operating Cash Flow
-8.5-7.27-6.48-6.2-4.29-1.15
Upgrade
Short-Term Debt Repaid
-----0.28-0.36
Upgrade
Total Debt Repaid
-----0.28-0.36
Upgrade
Net Debt Issued (Repaid)
-----0.28-0.36
Upgrade
Issuance of Common Stock
4.44.37--3.3633.65
Upgrade
Repurchase of Common Stock
----7.54--
Upgrade
Other Financing Activities
-----0.25-3.48
Upgrade
Financing Cash Flow
4.44.37--7.542.8429.81
Upgrade
Net Cash Flow
-4.1-2.9-6.48-13.74-1.4628.65
Upgrade
Levered Free Cash Flow
-1.85-1.49-3.42-3.4-2.59-0.45
Upgrade
Unlevered Free Cash Flow
-1.85-1.49-3.42-3.4-2.59-0.45
Upgrade
Change in Working Capital
0.331.270.03-0.12-0.390.03
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q